Zelefsky MJ, Kuban DA, Levy LB, et al. Multiinstitutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation[J]. International Journal of Radiation Oncology Biology Physics, 2007, 67(2): 327-333.
[4]
Danlos H, Bloch P. Note surle traitment du lupus erythemateux par des applications du radium[J]. Ann Dermatd Syphilog, 1901, 2(8): 986-988.
[5]
Goldberg SW, London ES. Zur frage der beziehungen zwischen becquerel-strahlen und hautaffectionen[J]. Dermatologische Zeitschrift, 1903, 10(5): 457-462.
[6]
Pasteau O, Degrais P. The radium treatment of cancer of the prostate[J]. Arch Roentgen Ray, 1914, 28(4): 396-410.
[7]
Hilaris BS, Whitmore WF, Batata MA, et al. Radiation therapy and pelvic node dissection in the management of cancer of the prostate[J]. American Journal of Roentgenology, 1974, 121(4): 832-838.
[8]
Whitmore WF, Hilaris B, Grabstald H. Retropublic implantation of iodine-125 in the treatment of prostate cancer[J]. Journal of Urology, 1972, 108(7): 918-920.
[9]
Holm HH, Juul N, Pedersen JF，et al. Transperineal 125-iodine seed implantation in prostatic cancer guided by transrectal ultrasonography[J]. Journal of Urology, 1983, 130(1): 283-286.
[10]
Blasko JC, Radge H, Schumacher D. Transperineal percutaneous iodine-125 implantation of prostatic carcinoma using transrectal ultrasound and template guidance[J]. Endocuriether Hypertherm Oncol, 1987, 3(1): 131-139.
[11]
John LR, David NC. X-ray-emitting interstitial implants: US, 4702228[P]. 1987-10-27.
[12]
Williamson JF. Brachytheragy technology and physics practice since 1950: a half-century of progress[J]. Physics in Medicine and Biology, 2006, 51(13): R303-R325.
[13]
王俊杰. 放射性粒子植入治疗肿瘤[J]. 当代医学，2009，15（29）：632634.
[14]
Murphy MK, Piper PK, Greenwood LR, et al. Evaluation of the new cesium-131 seed for use in low-energy X-ray brachytherapy[J]. Medical Physics, 2004, 31(6): 1 529-1 538.
Lazarescu GR, Battista JJ. Analysis of the radiobiology of ytterbium-169 and iodine-125 permanent brachytherapy implants[J]. Physics in Medicine and Biology, 1997, 42(9): 1 727-1 736.
[21]
Ling CC. Permanent implants using 198Au, 103Pd, and 125I: Radiobiological considerations based on the linear quadratic model[J]. International Journal of Radiation Oncology Biology Physics, 1992, 23(1): 81-87.
[22]
Prestidge BR, Prete JJ, Buchholz TA, et al. A survey of current clinical practice of permanent prostate brachytherapy in the United States[J]. International Journal of Radiation Oncology Biology Physics, 1998, 40(2): 461-465.
[23]
刘运祚. 常用放射性核素衰变纲图[M]. 北京：原子能出版社，1982.
[24]
Murphy MK, Piper RK, Greenwood LR, et al. Evaluation of the new cesium-131 seed for use in low-energy X-ray brachytherapy[J]. Medical Physics, 2004, 31(4): 1 529-1 538.
[25]
Armpilia CI, Dale RG, Coles IP, et al. The determination of radiobiologically optimized half-lives for radionuclides used in permanent brachytherapy implants[J]. International Journal of Radiation Oncology Biology Physics, 2003, 55(2): 378-385.
[26]
Bray LA, Richland WA. Method for preparing particles of radioactive powder containing Cesium-131 for use in brachytherapy sources: US, 7316644[P]. 2008-01-08.
[27]
Lee WR, Deguzman AF, Tomlinson SK, et al. Radioactive sources embedded in suture are associated with improved postimplant dosimetry in men treated with prostate brachytherapy[J]. Radiotherapy and Oncology, 2002, 65(2): 123-127.
[28]
Jay R, Mike R, Kevin H, et al. Products and methods for brachytherapy: US, 7322928[P]. 2008-01-29.
[29]
Langton MA, Lyman FJ, Reed JC. Apparatus and method for making carrier assembly for radioactive seed carrier: US, 5460592[P]. 1995-10-24.
Chen Z, Nath R. Biologically effective dose-(BED) for interstitial seed implants containing a mixture of radionuclides with different half-lives[J]. International Journal of Radiation Oncology Biology Physics, 2003, 55(3): 825-834.
[32]
Harder GF, Taghizadeh M. Hybrid source containing multi-radionuclides for use in radiation therapy: US, 20080249398[P]. 2008-10-09.
[33]
Lucas S, Nuttens V. Radiotherapy device and method: EP, 1846103[P]. 2007-10-24.
